Factor IX activity measurement of recombinant FIX Fc fusion protein eftrenonacog alfa with one-stage clotting and chromogenic substrate assay

被引：0
|
作者：
Prudkova, Marie [1 ,2 ,3 ,4 ]
Chytra, Dagmar [1 ,4 ]
Smejkal, Petr [1 ,4 ]
Zavrelova, Jirina [1 ,4 ]
Kovarikova, Jana [1 ,4 ]
Penka, Miroslav [1 ,2 ,3 ]
Bulikova, Alena [1 ,2 ,3 ]
机构：
[1] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic
[2] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[3] Masaryk Univ Brno, Fac Med, Brno, Czech Republic
[4] Masaryk Univ Brno, Dept Lab Methods, Fac Med, Brno, Czech Republic
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
chromogenic substrate assay; one-stage clotting assay; recombinant factor IX Fc fusion protein;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-074 (16
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [31] Assessment of recombinant factor IX-FC fusion protein (RFIXFC) clotting activity in plasma samples at canadian haemophilia treatment centres
    Geske, Jon F.
    Sadeghi-Khomami, A.
    Chaudhry, H. R.
    Sholzberg, M.
    Teitel, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 316 - 316
  • [32] Potency estimates for recombinant factor IX in the one-stage clotting assay are influenced by more than just the choice of activated partial thromboplastin time reagent
    Wilmot, Helen V.
    Gray, Elaine
    HAEMOPHILIA, 2018, 24 (05) : E363 - E368
  • [33] Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity
    Sommer, Jurg M.
    Yang Buyue
    Bardan, Sara
    Peters, Robert T.
    Jiang, Haiyan
    Kamphaus, George D.
    Gray, Elaine
    Pierce, Glenn F.
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (05) : 932 - 940
  • [34] Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study
    Hillarp, A.
    Bowyer, A.
    Ezban, M.
    Persson, P.
    Kitchen, S.
    HAEMOPHILIA, 2017, 23 (03) : 458 - 465
  • [35] Measurement of factor VIII activity using one-stage clotting assay: a calibration curve has not to be systematically included in each run
    Lattes, S.
    Appert-Flory, A.
    Fischer, F.
    Jambou, D.
    Toulon, P.
    HAEMOPHILIA, 2011, 17 (01) : 139 - 142
  • [36] Clotting and chromogenic factor VIII assay variability in post-infusion and spiked samples containing full-length recombinant FVIII or recombinant factor VIII Fc fusion protein (rFVIIIFc)
    Kitchen, Steve
    Jennings, Ian
    Makris, Mike
    Kitchen, Dianne Patricia
    Woods, Timothy A. L.
    Walker, Isobel D.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (02) : 176 - 183
  • [37] Comparison of the behavior of different factor VIII products measured with the chromogenic factor VIII activity assay and the FVIII one stage clotting assay
    Van Duren, C.
    Schutgens, R.
    Polenewen, R.
    Brons, P.
    Laros-Van Gorkom, B.
    Van Heerde, W. L.
    HAEMOPHILIA, 2014, 20 : 64 - 64
  • [38] Variability in combinations of APTT reagent and substrate plasma for a one-stage clotting assay to measure factor VIII products
    Suzuki, Atsuo
    Suzuki, Nobuaki
    Kanematsu, Takeshi
    Okamoto, Shuichi
    Suzuki, Naruko
    Tamura, Shogo
    Kikuchi, Ryosuke
    Katsumi, Akira
    Kojima, Tetsuhito
    Matsushita, Tadashi
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (04) : 705 - 713
  • [39] Comparison of one-stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII-Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single-centre, real-world experience of surgery
    Desage, Stephanie
    Nougier, Christophe
    Meunier, Sandrine
    Chamouard, Valerie
    Jousselme, Emilie
    Dargaud, Yesim
    Lienhart, Anne
    HAEMOPHILIA, 2024, 30 (02) : 538 - 544
  • [40] VALIDATION OF METHOD FOR DETERMINATION OF RECOMBINANT-FVIIA COAGULANT ACTIVITY IN PLASMA USING A ONE-STAGE CLOTTING ASSAY
    HANSEN, LL
    NIELSEN, FE
    HEDNER, U
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 865 - 865
12345